✦ LIBER ✦

Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma

✍ Scribed by Franz Ludwig Dumoulin; Thomas Gerhardt; Sybille Fuchs; Christian Scheurlen; Michael Neubrand; Günter Layer; Tilman Sauerbruch

Book ID: 118523850
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 169 KB
Volume: 57
Category: Article
ISSN: 1097-6779
DOI: 10.1016/s0016-5107(03)70021-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant photodynamic therapy as a ne

Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma : A Phase II pilot study

✍ Marcus Wiedmann; Karel Caca; Frieder Berr; Ingolf Schiefke; Andrea Tannapfel; Ch 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

## Abstract ## BACKGROUND Only 20–30% of patients with hilar cholangiocarcinomas (CC) are candidates for potentially curative resection. However, even after curative (R0) resection, these patients have a disease recurrence rate of up to 76%. The current prospective Phase II study investigated phot

Phase II study of capecitabine as pallia

Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment

✍ Martinez-Trufero, J; Isla, D; Adansa, J C; Irigoyen, A; Hitt, R; Gil-Arnaiz, I; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 306 KB

A phase II study of photodynamic therapy

A phase II study of photodynamic therapy (PDT) with aminolevulinic acid HCl (ALA) 20% topical solution + blue light vs ALA topical solution vehicle + blue light using spot and broad area application and incubation times of 1, 2 and 3 hours for the treatment

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 50 KB